Raymond James Financial Inc Charles River Laboratories International, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 222,959 shares of CRL stock, worth $33.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
222,959
Previous 231,720
3.78%
Holding current value
$33.2 Million
Previous $42.8 Million
21.55%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
610Shares Held
54.5MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$908 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$757 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$637 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$356 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$341 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.57B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...